debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after
: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the
case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under
). Convertible Securities: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition
receipt (DR). Convertible Securities: warrant or convertible debenture or other securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup
securitiesconvertible to stock. In case of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the
in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under Section 258 of the Securities and Exchange
of group report, disclose the changes in the holding of individuals, thegroup percentage of acquisition/disposition, the group percentage after theacquisition/disposition and the person(s) under
, Soi Sathupradit 58, Bangpongpang Sub-district, Yannawa District Bangkok10120 Phone 0-2284-1218 Fax 0-2294-0705 URL www.jsppharma.com Contact Person Contact Contact Name ฝ่ายผู้ลงทุนสัมพันธ์ - เลขานุการ